Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension, April 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 130 articles:
HTML format


 

Single Articles

  1. JASINSKA-STROSCHEIN M, Oszajca K, Switlik W, Ruchwa J, et al
    Treatment with platelet-derived growth factor (PDGF) and rock inhibitors is related to declined nerve growth factor (NGF) signaling in an experimental model of rat pulmonary hypertension.
    Pharmacol Rep. 2017;69:532-535.
    Abstract    

    Abstract available

  2. LEE HY, Yoo SM, Kim HR, Chun EJ, et al
    Diagnosis of Grave's disease with pulmonary hypertension on chest CT.
    Clin Imaging. 2017;43:188-193.
    Abstract    

    Abstract available

  3. FARES WH, Kaminski N
    Finally, Progress in Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction.
    Am J Respir Cell Mol Biol. 2017;56:421-422.
    Abstract    



  4. ZHANG W, Wang W, Liu J, Li J, et al
    Follistatin-like 1 protects against hypoxia-induced pulmonary hypertension in mice.
    Sci Rep. 2017;7:45820.
    Abstract    

    Abstract available

  5. MASCHKE SK, Renne J, Werncke T, Olsson KM, et al
    Chronic thromboembolic pulmonary hypertension: Evaluation of 2D-perfusion angiography in patients who undergo balloon pulmonary angioplasty.
    Eur Radiol. 2017 Mar 30. doi: 10.1007/s00330-017-4806.
    Abstract    

    Abstract available

  6. GALL H, Hoeper MM, Richter MJ, Cacheris W, et al
    An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan.
    Eur Respir Rev. 2017;26.
    Abstract    

    Abstract available

  7. LANG I, Meyer BC, Ogo T, Matsubara H, et al
    Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
    Eur Respir Rev. 2017;26.
    Abstract    

    Abstract available

  8. SIMONNEAU G, Torbicki A, Dorfmuller P, Kim N, et al
    The pathophysiology of chronic thromboembolic pulmonary hypertension.
    Eur Respir Rev. 2017;26.
    Abstract    

    Abstract available

  9. PEPKE-ZABA J, Ghofrani HA, Hoeper MM
    Medical management of chronic thromboembolic pulmonary hypertension.
    Eur Respir Rev. 2017;26.
    Abstract    

    Abstract available

  10. KAH TEIK C, Ahmad MF, Soon Leong Y, Mohamed Ismail NA, et al
    Pulmonary hypertension complicating systemic sclerosis: A successful pregnancy outcome.
    J Obstet Gynaecol. 2017 Mar 28:1-2. doi: 10.1080/01443615.2017.1284774.
    Abstract    



  11. ZENG X, Zhu L, Xiao R, Liu B, et al
    Hypoxia-Induced Mitogenic Factor Acts as a Nonclassical Ligand of Calcium-Sensing Receptor, Therapeutically Exploitable for Intermittent Hypoxia-Induced Pulmonary Hypertension.
    Hypertension. 2017 Mar 27. pii: HYPERTENSIONAHA.116.08743.
    Abstract    

    Abstract available

  12. GOMEZ SANCHEZ MA, Barrios Garrido-Lestache E
    Selection of the Best of 2016 in the Treatment of Pulmonary Hypertension.
    Rev Esp Cardiol (Engl Ed). 2017;70:305-306.
    Abstract    



  13. UMAR S, Partow-Navid R, Ruffenach G, Iorga A, et al
    Severe pulmonary hypertension in aging female apolipoprotein E-deficient mice is rescued by estrogen replacement therapy.
    Biol Sex Differ. 2017;8:9.
    Abstract    

    Abstract available

  14. D'ARSIGNY CL
    Treatment for Patients With Chronic Thromboembolic Pulmonary Hypertension: Where Does Balloon Pulmonary Angioplasty Sit in the Treatment Algorithm?
    Can J Cardiol. 2017;33:430-432.
    Abstract    



  15. FULORIA M, Aschner JL
    Persistent pulmonary hypertension of the newborn.
    Semin Fetal Neonatal Med. 2017 Mar 23. pii: S1744-165X(17)30039.
    Abstract    

    Abstract available

  16. DENG Y, Wu W, Guo S, Chen Y, et al
    Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension.
    Respir Res. 2017;18:53.
    Abstract    

    Abstract available

  17. MINAMI M, Arita T, Iwasaki H, Muta T, et al
    Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinib.
    Br J Haematol. 2017 Mar 24. doi: 10.1111/bjh.14608.
    Abstract    

    Abstract available

  18. TRACY MC, Cornfield DN
    The evolution of disease: chronic lung disease of infancy and pulmonary hypertension.
    Curr Opin Pediatr. 2017 Mar 23. doi: 10.1097/MOP.0000000000000490.
    Abstract    

    Abstract available

  19. BRODERICK-FORSGREN K, Davenport CA, Sivak JA, Hargett CW, et al
    Improving on the diagnostic characteristics of echocardiography for pulmonary hypertension.
    Int J Cardiovasc Imaging. 2017 Mar 24. doi: 10.1007/s10554-017-1114.
    Abstract    

    Abstract available

  20. STEVEN S, Oelze M, Brandt M, Ullmann E, et al
    Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension.
    Oxid Med Cell Longev. 2017;2017:4353462.
    Abstract    

    Abstract available

  21. MEDAROV B, Chaudhry H, Myint T
    Increasing Hypoxemia and Dyspnea in Mild Chronic Obstructive Pulmonary Disease.
    JAMA. 2017;317:1072-1073.
    Abstract    



  22. KOTH AM, Axelrod DM, Reddy S, Roth SJ, et al
    Institution of Veno-arterial Extracorporeal Membrane Oxygenation Does Not Lead to Increased Wall Stress in Patients with Impaired Myocardial Function.
    Pediatr Cardiol. 2017;38:539-546.
    Abstract    

    Abstract available

  23. VOGELMEIER CF
    [International competitive clinical research].
    Dtsch Med Wochenschr. 2016;141:1734.
    Abstract    



  24. GULICK AK, Garry FB, Holt TN, Retallick-Trennepohl K, et al
    Angus calves born and raised at high altitude adapt to hypobaric hypoxia by increasing alveolar ventilation rate but not hematocrit.
    J Anim Sci. 2016;94:4167-4171.
    Abstract    

    Abstract available

  25. PARK T, Park SH, Arora A
    Delayed High Output Heart Failure due to Arteriovenous Fistula Complicated with Herniated Disc Surgery.
    J Korean Med Sci. 2016;31:2051-2053.
    Abstract    

    Abstract available

  26. JIMENEZ J, Richter J, Nagatomo T, Salaets T, et al
    Progressive Vascular Functional and Structural Damage in a Bronchopulmonary Dysplasia Model in Preterm Rabbits Exposed to Hyperoxia.
    Int J Mol Sci. 2016;17.
    Abstract    

    Abstract available

  27. BRAUN SD, Platzek I, Danowski D, Zophel K, et al
    Clinical Relevance of Computed Tomography Pulmonary Venography.
    Heart Lung Circ. 2016;25:1154-1163.
    Abstract    

    Abstract available

  28. LEE Y, Kim HJ, Yoon H, Choi CM, et al
    Clinical Characteristics and Treatment Outcomes of Primary Pulmonary Artery Sarcoma in Korea.
    J Korean Med Sci. 2016;31:1755-1760.
    Abstract    

    Abstract available

  29. BADIANI B, Messori A
    Reply to Letter to the Editor - Targeted Treatments for Pulmonary Arterial Hypertension: Interpreting Outcomes by Network Meta-Analysis.
    Heart Lung Circ. 2016;25:1139.
    Abstract    



  30. CHEN GL, Jiang H, Zou F
    Upregulation of Transient Receptor Potential Canonical Channels Contributes to Endotoxin-Induced Pulmonary Arterial Stenosis.
    Med Sci Monit. 2016;22:2679-84.
    Abstract    

    Abstract available

  31. MONACO TJ, Davila CD
    Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension.
    Drug Des Devel Ther. 2016;10:1675-82.
    Abstract    

    Abstract available

  32. KOGUCHI N, Okada A, Choh S, Katayama K, et al
    Concomitant Systemic Sclerosis and Sarcoidosis with Combined Pulmonary Fibrosis and Emphysema.
    Intern Med. 2016;55:1331-5.
    Abstract    

    Abstract available

  33. GUO WQ, Li L, Su Q
    In regard to Badiani and Messori, "Targeted Treatments for Pulmonary Arterial Hypertension: Interpreting Outcomes by Network Meta-analysis".
    Heart Lung Circ. 2016;25:1137-1138.
    Abstract    



  34. RADEGRAN G, Kjellstrom B, Ekmehag B, Larsen F, et al
    Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.
    Scand Cardiovasc J. 2016;50:243-50.
    Abstract    

    Abstract available

  35. MATIELI L, Berezovsky A, Salomao SR, Allemann N, et al
    Ocular toxicity assessment of chronic sildenafil therapy for pulmonary arterial hypertension.
    Graefes Arch Clin Exp Ophthalmol. 2016.
    Abstract    

    Abstract available

  36. PAN HC, Wang KY, Liang KW
    Left Main Coronary Artery Stenting to Relieve Extrinsic Compression by a Giant Pulmonary Artery Aneurysm in a Patient with Idiopathic Pulmonary Artery Hypertension.
    Heart Lung Circ. 2016;25:e122-5.
    Abstract    

    Abstract available

  37. CARRATU P, Ventura VA, Maniscalco M, Dragonieri S, et al
    Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea.
    Sleep Breath. 2016;20:613-9.
    Abstract    

    Abstract available

  38. HERNANDEZ-SUAREZ DF, Lopez Menendez F, Lopez-Candales A
    Maximal systolic excursion of the tricuspid annulus is independent of right atrial size and function in chronic pulmonary hypertension.
    Echocardiography. 2017 Apr 7. doi: 10.1111/echo.13531.
    Abstract    

    Abstract available

  39. SUMIN AN, Arkhipov OG
    [Right ventricular diastolic function in patients with lung diseases in the absence or presence of pulmonary hypertension].
    Ter Arkh. 2017;89:54-60.
    Abstract    

    Abstract available

  40. JOHNS CS, Swift AJ, Rajaram S, Hughes PJ, et al
    Lung perfusion: MRI vs. SPECT for screening in suspected chronic thromboembolic pulmonary hypertension.
    J Magn Reson Imaging. 2017 Apr 4. doi: 10.1002/jmri.25714.
    Abstract    

    Abstract available

  41. WEATHERALD J, Farina S, Bruno N, Laveneziana P, et al
    Cardiopulmonary Exercise Testing in Pulmonary Hypertension.
    Ann Am Thorac Soc. 2017 Apr 4. doi: 10.1513/AnnalsATS.201610.
    Abstract    

    Abstract available

  42. SUGANO M, Yoshida H, Kurobe H, Arase H, et al
    Effects of Transplanted Human Cord Blood-Mononuclear Cells on Pulmonary Hypertension in Immunodeficient Mice and Their Distribution.
    J Med Invest. 2017;64.
    Abstract    

    Abstract available

  43. VAN EMPEL V, Knackstedt C, van Paassen P, Brunner-La Rocca HP, et al
    Just air good enough in pulmonary hypertension?
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    Abstract    



  44. OZ-TUNCER G, Olgunturk R, Pektas A, Cilsal E, et al
    The role of inflammatory biomarkers in CHD-associated pulmonary hypertension in children.
    Cardiol Young. 2017;27:255-260.
    Abstract    

    Abstract available

  45. PERROS F, de Man FS, Bogaard HJ, Antigny F, et al
    Use of beta-Blockers in Pulmonary Hypertension.
    Circ Heart Fail. 2017;10.
    Abstract    

    Abstract available

  46. ZHU L, Liu L, He X, Yan M, et al
    Association between genetic polymorphism of telomere-associated gene ACYP2 and the risk of HAPE among the Chinese Han population: A Case-control study.
    Medicine (Baltimore). 2017;96:e6504.
    Abstract    

    Abstract available

  47. MICHELS G, Pfister R
    [64-Year-Old Woman with Dyspnea and Shortened Phalanges].
    Dtsch Med Wochenschr. 2017;142:209.
    Abstract    



  48. TAKAHASHI S, Horie R, Yokoyama Y
    Pharmacological and clinical profile of a novel dual endothelin receptor antagonist, macitentan (Opsumit(R)).
    Nihon Yakurigaku Zasshi. 2017;149:49-58.
    Abstract    



  49. HAO M, Li M, Li W
    Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension.
    Mol Med Rep. 2017;15:160-168.
    Abstract    

    Abstract available

  50. EYRIES M, Soubrier F
    Molecular Genetic Diagnosis of Pulmonary Arterial Hypertension: An Increased Complexity.
    Rev Esp Cardiol (Engl Ed). 2016;69:1003-1004.
    Abstract    



  51. NAVAS P, Tenorio J, Quezada CA, Barrios E, et al
    Molecular Analysis of BMPR2, TBX4, and KCNK3 and Genotype-Phenotype Correlations in Spanish Patients and Families With Idiopathic and Hereditary Pulmonary Arterial Hypertension.
    Rev Esp Cardiol (Engl Ed). 2016;69:1011-1019.
    Abstract    

    Abstract available

  52. SZTURMOWICZ M, Kacprzak A, Burakowska B, Skoczylas A, et al
    Centrilobular nodules in high resolution computed tomography of the lung in IPAH patients - preliminary data concerning clinico-radiological correlates.
    Pneumonol Alergol Pol. 2016;84:265-70.
    Abstract    

    Abstract available

  53. MAEDA NY, Clave MM, Bydlowski SP, Lopes AA, et al
    Decreased circulating thrombomodulin is improved by tadalafil therapy in hypoxemic patients with advanced pulmonary arterial hypertension.
    Thromb Res. 2016;146:15-19.
    Abstract    

    Abstract available

  54. BOCCARA F, Cohen A
    HIV and Heart Disease: What Cardiologists Should Know.
    Rev Esp Cardiol (Engl Ed). 2016;69:1126-1130.
    Abstract    



  55. PLESNER LL, Schoos MM, Dalsgaard M, Goetze JP, et al
    Iron Deficiency in COPD Associates with Increased Pulmonary Artery Pressure Estimated by Echocardiography.
    Heart Lung Circ. 2017;26:101-104.
    Abstract    

    Abstract available

  56. YUAN Y, Zhang Y, Zhang X, Yu Y, et al
    Deciphering the genetic and modular connections between coronary heart disease, idiopathic pulmonary arterial hypertension and pulmonary heart disease.
    Mol Med Rep. 2016;14:661-70.
    Abstract    

    Abstract available

  57. KWAPISZEWSKA G, Hoffmann J, Kovacs G, Stacher E, et al
    [Pulmonary (Arterial) Hypertension].
    Pneumologie. 2016;70:630-637.
    Abstract    

    Abstract available

  58. ZHANG L, Zhao S, Ma J, Gong J, et al
    Prevalence and risk factors for pulmonary arterial hypertension in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis.
    Ren Fail. 2016.
    Abstract    

    Abstract available

  59. COUGHLIN MA, Werner NL, Gajarski R, Gadepalli S, et al
    Prenatally diagnosed severe CDH: mortality and morbidity remain high.
    J Pediatr Surg. 2016;51:1091-5.
    Abstract    

    Abstract available

  60. AMIRJANIANS M, Egemnazarov B, Sydykov A, Kojonazarov B, et al
    Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension.
    Oncotarget. 2017 Mar 31. doi: 10.18632/oncotarget.16769.
    Abstract    

    Abstract available

  61. SCHUOLER C, Haider TJ, Leuenberger C, Vogel J, et al
    Aquaporin 1 controls the functional phenotype of pulmonary smooth muscle cells in hypoxia-induced pulmonary hypertension.
    Basic Res Cardiol. 2017;112:30.
    Abstract    

    Abstract available

  62. GAO XY, Feng L, Qiu YF, Pan XN, et al
    [Application of humidified high-flow nasal cannula in neonates with meconium aspiration syndrome and pulmonary hypertension after extubation].
    Zhongguo Dang Dai Er Ke Za Zhi. 2017;19:393-397.
    Abstract    

    Abstract available

  63. JIA D, He Y, Zhu Q, Liu H, et al
    RAGE-mediated extracellular matrix proteins accumulation exacerbates HySu-induced pulmonary hypertension.
    Cardiovasc Res. 2017 Apr 11. doi: 10.1093.
    Abstract    

    Abstract available

  64. HERESI GA, Platt DM, Wang W, Divers CH, et al
    Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia.
    BMC Pulm Med. 2017;17:58.
    Abstract    

    Abstract available

  65. CORREALE M, Brunetti ND, Di Biase M, Morandi F, et al
    [European guidelines on pulmonary hypertension].
    G Ital Cardiol (Rome). 2017;18:169.
    Abstract    




  66. Retracted: Mice lacking the Raf-1 kinase inhibitor protein exhibit exaggerated hypoxia-induced pulmonary hypertension, by I Morecroft, B Doyle, M Nilsen, W Kolch, K Mair and MR MacLean. British Journal of Pharmacology, volume 163(5): 948-963, publishe
    Br J Pharmacol. 2017;174:911.
    Abstract    

    Abstract available

  67. CHEN Z, Wang Q
    Activation of PPARgamma by baicalin attenuates pulmonary hypertension in an infant rat model by suppressing HMGB1/RAGE signaling.
    FEBS Open Bio. 2017;7:477-484.
    Abstract    

    Abstract available

  68. COVELLA M, Rowin EJ, Hill NS, Preston IR, et al
    Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy.
    Circ Heart Fail. 2017;10:e003689.
    Abstract    

    Abstract available

  69. MERKUS D, Schermuly RT
    Farnesylation of RhoB: the cancer hypothesis of pulmonary hypertension revisited.
    Cardiovasc Res. 2017;113:249-250.
    Abstract    



  70. DULUC L, Ahmetaj-Shala B, Mitchell J, Abdul-Salam VB, et al
    Tipifarnib prevents development of hypoxia-induced pulmonary hypertension.
    Cardiovasc Res. 2017;113:276-287.
    Abstract    

    Abstract available

  71. AKBAY NO, Bingol Z, Kiyan E, Karaayvaz EB, et al
    Fractional Exhaled Nitric Oxide Measurement in Pulmonary Hypertension: A Follow-Up Study.
    Clin Appl Thromb Hemost. 2017 Jan 1:1076029617702243.
    Abstract    

    Abstract available

  72. ESLAM RB, Croce K, Mangione FM, Musmann R, et al
    Persistence and proliferation of human mesenchymal stromal cells in the right ventricular myocardium after intracoronary injection in a large animal model of pulmonary hypertension.
    Cytotherapy. 2017 Apr 6. pii: S1465-3249(17)30426.
    Abstract    

    Abstract available

  73. CARPENTIER E, Mur S, Aubry E, Pognon L, et al
    Safety and tolerability of subcutaneous treprostinil in newborns with congenital diaphragmatic hernia and life-threatening pulmonary hypertension.
    J Pediatr Surg. 2017 Mar 28. pii: S0022-3468(17)30207.
    Abstract    

    Abstract available

  74. BONAFEDE RJ, Calvo JP, Fausti JM, Puebla S, et al
    Nitric oxide: A new possible biomarker in heart failure? Relationship with pulmonary hypertension secondary to left heart failure.
    Clin Investig Arterioscler. 2017 Apr 5. pii: S0214-9168(17)30016.
    Abstract    

    Abstract available

  75. JOHNS CS, Swift AJ, Hughes PJ, Ohno Y, et al
    Pulmonary MR angiography and perfusion imaging-A review of methods and applications.
    Eur J Radiol. 2017;86:361-370.
    Abstract    

    Abstract available

  76. SUGAWARA E, Kato M, Hisada R, Oku K, et al
    Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and Cyclophosphamide.
    Intern Med. 2017;56:445-448.
    Abstract    

    Abstract available

  77. ZISOWSKY J, Gehin M, Kusic-Pajic A, Krause A, et al
    Pediatric Development of Bosentan Facilitated by Modeling and Simulation.
    Paediatr Drugs. 2017;19:121-130.
    Abstract    

    Abstract available

  78. MICHELFELDER M, Becker M, Riedlinger A, Siegert E, et al
    Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Clin Rheumatol. 2017;36:381-390.
    Abstract    

    Abstract available

  79. ZHAO H, Xue Y, Guo Y, Sun Y, et al
    Inhibition of endocan attenuates monocrotaline-induced connective tissue disease related pulmonary arterial hypertension.
    Int Immunopharmacol. 2017;42:115-121.
    Abstract    

    Abstract available

  80. CLIFT P, Celermajer D
    Managing adult Fontan patients: where do we stand?
    Eur Respir Rev. 2016;25:438-450.
    Abstract    

    Abstract available

  81. OLSSON KM, Channick R
    Pregnancy in pulmonary arterial hypertension.
    Eur Respir Rev. 2016;25:431-437.
    Abstract    

    Abstract available

  82. FARBER HW, Gin-Sing W
    Practical considerations for therapies targeting the prostacyclin pathway.
    Eur Respir Rev. 2016;25:418-430.
    Abstract    

    Abstract available

  83. SITBON O, Gaine S
    Beyond a single pathway: combination therapy in pulmonary arterial hypertension.
    Eur Respir Rev. 2016;25:408-417.
    Abstract    

    Abstract available

  84. GRAARUP J, Ferrari P, Howard LS
    Patient engagement and self-management in pulmonary arterial hypertension.
    Eur Respir Rev. 2016;25:399-407.
    Abstract    

    Abstract available

  85. RAINA A, Humbert M
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir Rev. 2016;25:390-398.
    Abstract    

    Abstract available

  86. SIMONNEAU G, Hoeper MM, McLaughlin V, Rubin L, et al
    Future perspectives in pulmonary arterial hypertension.
    Eur Respir Rev. 2016;25:381-389.
    Abstract    

    Abstract available

  87. HARARI S
    The revolution of pulmonary arterial hypertension.
    Eur Respir Rev. 2016;25:361-363.
    Abstract    



  88. ILGEN U, Yayla ME, Duzgun N
    Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis.
    Clin Rheumatol. 2017;36:367-372.
    Abstract    

    Abstract available

  89. ZHENG Z, Yu S, Zhang W, Peng Y, et al
    Genistein attenuates monocrotaline-induced pulmonary arterial hypertension in rats by activating PI3K/Akt/eNOS signaling.
    Histol Histopathol. 2017;32:35-41.
    Abstract    

    Abstract available

  90. ITO T, Tamura N, Okuda S, Tada K, et al
    Elevated serum levels of soluble CD146 in patients with systemic sclerosis.
    Clin Rheumatol. 2017;36:119-124.
    Abstract    

    Abstract available

  91. SURANI SR, Mendez Y, Anjum H, Varon J, et al
    Pulmonary complications of hepatic diseases.
    World J Gastroenterol. 2016;22:6008-15.
    Abstract    

    Abstract available

  92. KAMELY M, Karimi Torshizi MA, Rahimi S
    Blood biochemistry, thyroid hormones, and performance in broilers with ascites caused by caffeine.
    Poult Sci. 2016;95:2673-2678.
    Abstract    

    Abstract available

  93. KILCHEMMANN FUENTES C, Vallejos Vallejos C, Roman Navarro A
    [Cost effectiveness and budget impact analysis of inhaled nitric oxide in a neonatal unit from the perspective of the public health system].
    Rev Chil Pediatr. 2016;87:463-467.
    Abstract    

    Abstract available

  94. CHELLADURAI P, Seeger W, Pullamsetti SS
    Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives.
    Eur Respir Rev. 2016;25:135-40.
    Abstract    

    Abstract available

  95. SZTURMOWICZ M, Kacprzak A, Franczuk M, Burakowska B, et al
    Low DLCO in idiopathic pulmonary arterial hypertension - clinical correlates and prognostic significance.
    Pneumonol Alergol Pol. 2016;84:87-94.
    Abstract    

    Abstract available

  96. DOMINGUEZ MANZANO P, Mendoza Soto A, Roman Barba V, Moreno Galdo A, et al
    Pulmonary Arterial Hypertension and Neonatal Arterial Switch Surgery for Correction of Transposition of the Great Arteries.
    Rev Esp Cardiol (Engl Ed). 2016;69:836-41.
    Abstract    

    Abstract available

  97. AHMED I, Hassan Nuri MM, Zakariyya AN, Ahmad SM, et al
    Correlation Between Doppler Echocardiography and Right Heart Catheterization Derived Pulmonary Artery Pressures: Impact of Right Atrial Pressures.
    J Coll Physicians Surg Pak. 2016;26:255-9.
    Abstract    

    Abstract available

  98. HAN X, Zhang Y, Zhou Z, Zhang X, et al
    Hydroxysafflor yellow A improves established monocrotaline-induced pulmonary arterial hypertension in rats.
    J Int Med Res. 2016;44:569-84.
    Abstract    

    Abstract available

  99. TAKEUCHI T, Sakao S, Kato F, Naito A, et al
    Pulmonary haemodynamics are correlated with intimal lesions in a rat model of severe PAH: attenuation of pulmonary vascular remodelling with ambrisentan.
    Histol Histopathol. 2016;31:1357-65.
    Abstract    

    Abstract available

  100. TAKAHASHI T, Friedmacher F, Zimmer J, Puri P, et al
    Increased c-kit and stem cell factor expression in the pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia.
    J Pediatr Surg. 2016 Feb 11. pii: S0022-3468(16)00070.
    Abstract    

    Abstract available

  101. KO T, Hatano M, Nitta D, Muraoka H, et al
    A case of interferon-alpha-induced pulmonary arterial hypertension after living donor liver transplantation.
    Heart Vessels. 2016;31:1206-8.
    Abstract    

    Abstract available

  102. MARUOKA Y, Nagao M, Baba S, Isoda T, et al
    Three-dimensional fractal analysis of 99mTc-MAA SPECT images in chronic thromboembolic pulmonary hypertension for evaluation of response to balloon pulmonary angioplasty: association with pulmonary arterial pressure.
    Nucl Med Commun. 2017 Apr 20. doi: 10.1097/MNM.0000000000000673.
    Abstract    

    Abstract available

  103. FREITAS CSG, Baldi BG, Jardim C, Araujo MS, et al
    Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method.
    Orphanet J Rare Dis. 2017;12:74.
    Abstract    

    Abstract available

  104. KULA S, Pektas A
    A review of pediatric pulmonary hypertension with new guidelines.
    Turk J Med Sci. 2017;47:375-380.
    Abstract    

    Abstract available

  105. KASAI H, Tanabe N, Koshikawa K, Hirasawa Y, et al
    The Development of Marked Collateral Circulation due to Inferior Vena Cava Filter Occlusion in a Patient with Chronic Thromboembolic Pulmonary Hypertension Complicated with Anti-phospholipid Syndrome.
    Intern Med. 2017;56:931-936.
    Abstract    

    Abstract available

  106. XU Y, Xu W, Liu Y, Tian X, et al
    Pulmonary hypertension associated with combined fibrosing mediastinitis and bronchial anthracofibrosis: A retrospective analysis in a single Chinese hospital.
    Clin Respir J. 2017 Apr 17. doi: 10.1111/crj.12641.
    Abstract    

    Abstract available

  107. MADABHAVI I, Revannasiddaiah S, Sarkar M
    Classical image of the pulmonary artery aneurysm secondary to idiopathic pulmonary hypertension.
    Clin Respir J. 2017 Apr 17. doi: 10.1111/crj.12642.
    Abstract    



  108. LUSCHER TF
    From systemic and pulmonary hypertension to heart failure: novel drugs and devices.
    Eur Heart J. 2017;38:1087-1090.
    Abstract    



  109. FAURE M, Gomez E, Dorfmuller P, Mandry D, et al
    A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation.
    Respir Med Case Rep. 2017;21:74-77.
    Abstract    

    Abstract available

  110. DAVIS C, Hackett P
    Advances in the Prevention and Treatment of High Altitude Illness.
    Emerg Med Clin North Am. 2017;35:241-260.
    Abstract    

    Abstract available

  111. ZUILY S, Domingues V, Suty-Selton C, Eschwege V, et al
    Antiphospholipid Antibodies Can Identify Lupus Patients At Risk Of Pulmonary Hypertension: A Systematic Review And Meta-Analysis.
    Autoimmun Rev. 2017 Apr 11. pii: S1568-9972(17)30098.
    Abstract    

    Abstract available

  112. BERTHELOT E, Bailly MT, Hatimi SE, Robard I, et al
    Pulmonary hypertension due to left heart disease.
    Arch Cardiovasc Dis. 2017 Apr 11. pii: S1875-2136(17)30062.
    Abstract    

    Abstract available

  113. PENG JJ, Liu B, Xu JY, Peng J, et al
    NADPH oxidase: its potential role in promotion of pulmonary arterial hypertension.
    Naunyn Schmiedebergs Arch Pharmacol. 2017;390:331-338.
    Abstract    

    Abstract available

  114. TARTAVOULLE TM
    Management of Sepsis in Patients with Pulmonary Arterial Hypertension in the Intensive Care Unit.
    Crit Care Nurs Clin North Am. 2017;29:15-23.
    Abstract    

    Abstract available

  115. XIAO T, Xie L, Huang M, Shen J, et al
    Differential expression of microRNA in the lungs of rats with pulmonary arterial hypertension.
    Mol Med Rep. 2017;15:591-596.
    Abstract    

    Abstract available

  116. ZIDOUH S, Jidane S, Belkouch A, Bakkali H, et al
    Akinetic mutism revealing an ischemic stroke.
    Am J Emerg Med. 2017;35:666.
    Abstract    

    Abstract available

  117. LEI W, He Y, Shui X, Li G, et al
    Expression and analyses of the HIF-1 pathway in the lungs of humans with pulmonary arterial hypertension.
    Mol Med Rep. 2016;14:4383-4390.
    Abstract    

    Abstract available

  118. PINCEZ T, Calamy L, Germont Z, Lemoine A, et al
    [Pulmonary complications of sickle cell disease in children].
    Arch Pediatr. 2016;23:1094-1106.
    Abstract    

    Abstract available

  119. AKTER F, Coghlan G, de Mel A
    Nitric oxide in paediatric respiratory disorders: novel interventions to address associated vascular phenomena?
    Ther Adv Cardiovasc Dis. 2016;10:256-70.
    Abstract    

    Abstract available

  120. TSAI MH, Wu IH, Lee CW, Chu SM, et al
    Neonatal gram-negative bacillary late-onset sepsis: A case-control-control study on a prospectively collected database of 5,233 admissions.
    Am J Infect Control. 2016;44:146-53.
    Abstract    

    Abstract available

  121. SADA Y, Dohi Y, Uga S, Higashi A, et al
    Non-suppressive regulatory T cell subset expansion in pulmonary arterial hypertension.
    Heart Vessels. 2016;31:1319-26.
    Abstract    

    Abstract available

  122. BATTAGLIA S, Bellia M, Serafino-Agrusa L, Giardina A, et al
    Physical capacity in performing daily activities is reduced in scleroderma patients with early lung involvement.
    Clin Respir J. 2017;11:36-42.
    Abstract    

    Abstract available

  123. CHIZINGA M, Rudkovskaia AA, Henderson K, Pollak J, et al
    Pulmonary Hypertension Prevalence and Prognosis in a Cohort of Patients with Hereditary Hemorrhagic Telangiectasia Undergoing Embolization of pAVMs.
    Am J Respir Crit Care Med. 2017 Apr 4. doi: 10.1164/rccm.201702-0267.
    Abstract    



  124. XAVIER J, Haranal MY, Reddy SR, Suryaprakash S, et al
    A Rare Case of Mitral Valve Prolapse in Endomyocardial Fibrosis.
    Ann Thorac Surg. 2016;102:e217-9.
    Abstract    

    Abstract available

  125. PATEL HJ, Likosky DS, Pruitt AL, Murphy ET, et al
    Aortic Valve Replacement in the Moderately Elevated Risk Patient: A Population-Based Analysis of Outcomes.
    Ann Thorac Surg. 2016 Jun 18. pii: S0003-4975(16)30368.
    Abstract    

    Abstract available

  126. GUAZZI M, Naeije R
    Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives.
    J Am Coll Cardiol. 2017;69:1718-1734.
    Abstract    

    Abstract available

  127. ANTUNES MJ
    Pulmonary hypertension and mitral valve disease: Still a beast.
    J Thorac Cardiovasc Surg. 2017;153:1083-1084.
    Abstract    



  128. YANG B, Likosky DS, Bolling SF
    Mitral stenosis with pulmonary hypertension: We should operate early.
    J Thorac Cardiovasc Surg. 2017;153:1082-1083.
    Abstract    



  129. REVIRON-RABEC L, Girerd B, Seferian A, Campbell K, et al
    Pulmonary complications of type 1 neurofibromatosis.
    Rev Mal Respir. 2016;33:460-73.
    Abstract    

    Abstract available

  130. GOYARD C, Sanchez O, Mourin G, Mussot S, et al
    [Angiosarcoma mimicking recurrent pulmonary embolism].
    Rev Mal Respir. 2016;33:377-82.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;